Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729946 · ClinicalTrials.gov registry record · NA
Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04729946 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 6 participants.
The verdict
NCT04729946, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The Pure-Vu® System can be effectively used as a cleansing device in patients admitted with acute LGIB to the intensive care unit and the regular nurse floor (RNF) bypassing the need to administer an oral bowel preparation for adequate visualization and hence decreasing time to colonoscopy and improving diagnostic and therapeutic yield.
Interventions
- DEVICE Pure-Vu Cleansing Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2022-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04729946
The ClinicalTrials.gov registry entry for NCT04729946 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pure-Vu Cleansing Device is the first listed.
NCT04729946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04729946 about?
NCT04729946 is a clinical study titled "Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System". The Pure-Vu® System can be effectively used as a cleansing device in patients admitted with acute LGIB to the intensive care unit and the regular nurse floor (RNF) bypassing the need to administer an oral bowel preparation for adequate visualization and hence decreasing time to colonoscopy and impro...
What is the current status of trial NCT04729946?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-03. Estimated completion is 2022-04-06.
What interventions are being tested in trial NCT04729946?
The interventions under investigation include: Pure-Vu Cleansing Device (DEVICE).
Who is sponsoring clinical trial NCT04729946?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.